Pilot whole genome sequencing service

Pilot whole genome sequencing service: Bupa becomes first UK major private healthcare provider to pilot whole genome sequencing for selected UK customers, identifying risk of...

Prostate cancer survival rates

Patients with localised prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of the condition remain high....

Prostate cancer: “liquid biopsies”

Prostate cancer: "liquid biopsies" allow non-invasive diagnosis of metastatic cancers: In future, newly identified biomarkers could be used alongside imaging techniques for the non-invasive diagnosis...